Literature DB >> 7608489

Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction.

P Marcellin1, M Pouteau, J P Benhamou.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608489     DOI: 10.1016/0168-8278(95)80291-6

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  16 in total

Review 1.  Autoimmune hepatitis and its variant syndromes.

Authors:  Z Ben-Ari; A J Czaja
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

Review 2.  Tolerability of treatments for viral hepatitis.

Authors:  A Gervais; N Boyer; P Marcellin
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 3.  Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations.

Authors:  Chiaki Okuse; Hiroshi Yotsuyanagi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

Review 4.  Thyroid dysfunction from antineoplastic agents.

Authors:  Ole-Petter Riksfjord Hamnvik; P Reed Larsen; Ellen Marqusee
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506

Review 5.  Nonhepatic manifestations and combined diseases in HCV infection.

Authors:  S J Hadziyannis
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

6.  Subacute thyroiditis during interferon-alpha therapy for chronic hepatitis C.

Authors:  P Falaschi; A Martocchia; R D'Urso; A Proietti
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

7.  Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.

Authors:  N Custro; G Montalto; V Scafidi; M Soresi; S Gallo; S Tripi; A Notarbartolo
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

8.  Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection: an AIGO study.

Authors:  A Andriulli; V Festa; G Leandro; M Rizzetto
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

9.  Cost effectiveness of combination therapy for hepatitis C: a decision analytic model.

Authors:  K Stein; W Rosenberg; J Wong
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

10.  Thyroid autoantibodies and thyroid dysfunction during treatment with interferon-alpha for chronic hepatitis C.

Authors:  K Kiehne; S Kloehn; H Hinrichsen; B Gallwitz; H Mönig
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.